Cincinnati Opioid Lawyer Reviewing Overdoses & Recalls - The Lyon Firm
« Back to Blog

Cincinnati Opioid Lawyer Reviewing Overdoses & Recalls

Ohio Product Liability Attorneys & Cincinnati Opioid Lawyer Warn on Continuing Health Hazards


According to the U.S. Centers for Disease Control and Prevention (CDC), drug overdoses killed 63,632 Americans in 2016—around 66 percent involved a prescription or illicit opioid like illicitly manufactured fentanyl, oxycodone, hydrocodone, morphine and methadone. Overprescribing and addiction appears to be worsening in Ohio and in October, 2017, the opioid epidemic was declared a national public health emergency.

In related news, a recall of the opioid overdose antidote Naloxone was announced after the U.S. Food and Drug Administration (FDA) reported a possibility of “loose particulate matter on the syringe plunger” that could pose a number of health risks, including allergic reactions and a range of cardiovascular issues, including blood clots.

Recently, FDA Commissioner Scott Gottlieb, M.D., announced a one day Online Opioid Summit to discuss ways to combat the opioid crisis by reducing the availability of illicit opioids online. Gottlieb invited internet stakeholders, government officials, researchers, and safety advocacy groups to the Summit on June 27, 2018.

Joe Lyon is a highly-rated Cincinnati Opioid Lawyer and toxic tort attorney representing plaintiffs nationwide in a wide variety of Ohio product liability claims against pharmaceutical companies. 


Illegal Internet Opioid Sales

The Food and Drug Administration is cracking down on websites like “AnonShop,” “Remedy Mart,” “TramadolHub” and “One Stop Pharma” that are illegally selling opioid medications online to residents in Ohio, including tramadol and oxycodone, extremely potent painkillers.

The FDA warned about 53 websites to stop selling the products or face a regulatory action, such as having the products seized. The FDA Commissioner described the internet as “virtually awash in illegal narcotics,” and implied that additional actions would be coming.

motrin recall lawyer cincinnati opioid lawyer


FDA Action Plan Reviewed by Cincinnati Opioid Lawyer

The FDA has been inundated with weekly bad news regarding the epidemic of opioid abuse and overdose deaths in the United States. In response to the opioid crisis in Ohio and across the country, the federal safety agency has developed a plan to reduce the impact of opioid abuse in the U.S. The FDA has said it is committed to enhancing safety labeling, requiring new data, and seeking to improve pain treatment. The FDA Opioid Action Plan will include:

  • Expanded use of advisory committees—the FDA will convene an expert advisory committee before approving any New Drug Application for an opioid that does not have abuse-deterrent properties.
  • Develop warnings and safety information for immediate-release opioid labeling. The FDA is developing additional warnings and safety information.
  • Strengthen post-market requirements—the FDA is strengthening the requirements for drug companies to generate post-market data on the long-term impact of using opioids.
  • Update Risk Evaluation and Mitigation Strategy (REMS) Program—The aim is to increase the number of prescribers who receive training on pain management and safe prescribing of opioid drugs in order to decrease inappropriate opioid prescribing.
  • Expand access to abuse-deterrent formulations (ADFs) to discourage abuse. The pharmaceutical industry has shown significant interest in developing ADFs and the technology is progressing rapidly.
  • Support better treatment. The FDA is reviewing options, including over-the-counter availability, to make naloxone more accessible to treat opioid overdose.

 If you or a loved one has suffered an injury due to prescription opioid drugs in Ohio, and have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403 in Cincinnati.

You will speak directly with Mr. Lyon, a Cincinnati Opioid Lawyer. He will help you answer critical questions regarding the new FDA opioid measures.

Contact us today.